The Department of Health and Human Services is winding down its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA), the agency announced Tuesday.

“We reviewed the science, listened to the experts, and acted,” HHS Secretary Robert F. Kennedy, Jr said in a statement. The wind-down will include canceling some contracts, he added.

“BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu. We’re shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate.”

HHS's decision comes after it said it conducted a "comprehensive review" of mRNA-related investments that began

See Full Page